VaccineHumansInfluenza VaccinesFemaleMaleInfant
Tolerability, safety, and preliminary immunogenicity assessment of different dosages of Quadrivalent inactivated influenza vaccine in healthy subjects aged 6-35 months: A single-center, dose-escalation, open-label phase I clinical trial.
Yinbiao Zhu, Mengxue Si, Lei Wang, Yunyun Zhang, Tianxin Zhu, Jianhua Wu, Yun Zhang, Qi Shuai, Wei Lu, Wenlin Ma, Mengyuan Zhao, Shihui Zhu, Yang Tang, Jun Yu
Published: 202510.1016/j.vaccine.2025.127962
Abstract
This study aims to evaluate the tolerability, safety, and preliminary immunogenicity of quadrivalent influenza virus split vaccine (IIV4) in healthy infants and young children aged 6-35 months across different dosages. Employing a single-center, dose…
Preview only. Read the full abstract at the source